Cambridge scientists created a gel that could end arthritis pain

Cambridge scientists have created a breakthrough material that can sense tiny chemical changes in the body, such as the increased acidity during an arthritis flare-up, and release drugs exactly when and where they’re needed. By mimicking cartilage while delivering medication, this smart gel could ease pain, reduce side effects, and provide continuous treatment for millions of arthritis sufferers.

Read more

Sneezing from cats or dust? Safe UV light may neutralize allergens in minutes

Sneezing from cats, dust mites, or mold may one day be preventable with a flip of a switch. Researchers at CU Boulder found that UV222 light can alter allergen proteins, reducing allergic reactions without dangerous side effects. Within 30 minutes, airborne allergens decreased by up to 25%. The team imagines portable devices that could shield people in homes, schools, and workplaces from harmful triggers.

Read more

The hidden group that loses COVID protection fast

Why do some people stay protected after vaccination while others quickly lose immunity? Researchers in Japan tracked over 2,500 people for 18 months and found four distinct immune response patterns. The so-called “rapid-decliners” looked strong at first but lost antibodies quickly, leaving them more vulnerable to infection.

Read more

Common denominator that triggers asthma in favorable environments

Some so-called pro-allergic environments strongly promote the development of asthma and are responsible for the dramatic increase in the prevalence of asthma, especially in industrialized countries. Researchers at the GIGA of the University of Liège have identified how all these pro-allergic environments act in the same way on the pulmonary immune system to induce the development of allergic asthma.

Read more

Three-in-one inhaler therapy can improve lung function and reduce asthma attacks

Patients with severe asthma which is not controlled with standard treatment — leaving them at risk of severe asthma attacks — could benefit from using a single inhaler combining three, instead of 2 therapies, according to two phase 3 randomized controlled trials with over 2,500 patients across 17 countries.

Read more